Page last updated: 2024-11-06

alloxan and Cranial Nerve II Diseases

alloxan has been researched along with Cranial Nerve II Diseases in 2 studies

Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.

Research Excerpts

ExcerptRelevanceReference
"Lycopene (4 mg/kg) was administered to the rats in LG once a day for 3 months."1.51The effects of lycopene on alloxan induced diabetic optic neuropathy. ( Elpeze, B; Icel, A; Icel, E; Karakurt, Y; Keskin Çimen, F; Süleyman, H; Uçak, T, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Icel, E1
Icel, A1
Uçak, T1
Karakurt, Y1
Elpeze, B1
Keskin Çimen, F1
Süleyman, H1
Apaydin, C1
Oğuz, Y1
Ağar, A1
Yargiçoğlu, P1
Demir, N1
Aksu, G1

Other Studies

2 other studies available for alloxan and Cranial Nerve II Diseases

ArticleYear
The effects of lycopene on alloxan induced diabetic optic neuropathy.
    Cutaneous and ocular toxicology, 2019, Volume: 38, Issue:1

    Topics: Alloxan; Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Diabetic

2019
Visual evoked potentials and optic nerve histopathology in normal and diabetic rats and effect of ginkgo biloba extract.
    Acta ophthalmologica, 1993, Volume: 71, Issue:5

    Topics: Administration, Oral; Alloxan; Animals; Diabetes Mellitus, Experimental; Evoked Potentials, Visual;

1993